Raloxifene Hydrochloride 71209-0082-13
- Manufacturer
- Cadila Pharmaceuticals Limited
- Dosage Form
- Tablet, Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 30, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA211324
Need to source Raloxifene Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Raloxifene Hydrochloride | 60 mg/1 |
Drug Class
Estrogen Agonist/Antagonist [EPC]Selective Estrogen Receptor Modulators [MoA]
Selected Package
71209-0082-13Selected2000 TABLET, COATED in 1 BOTTLE (71209-082-13)
Other packages for this product(3)
30 TABLET, COATED in 1 BOTTLE (71209-082-01)
100 TABLET, COATED in 1 BOTTLE (71209-082-05)
1000 TABLET, COATED in 1 BOTTLE (71209-082-11)